Add up to 500 Eli Lilly workers to the pharma layoff toll. The Indianapolis-based pharma plans to offer buyout packages to 2,000 manufacturing and engineering employees who work on active ingredients for Humalog and Humulin insulin products and the Forteo osteoporosis med. The deals are designed to cut up to 500 jobs, primarily in manufacturing, but a few in R&D as well. Report